Abstract 12: Serum carbonic anhydrase IX (CAIX) as diagnostic biomarker in clear cell renal cell carcinoma (ccRCC) patients .

@article{Knott2013Abstract1S,
  title={Abstract 12: Serum carbonic anhydrase IX (CAIX) as diagnostic biomarker in clear cell renal cell carcinoma (ccRCC) patients .},
  author={M. E. Knott and M. N{\'u}{\~n}ez and M. Quiroga and Gast{\'o}n Boggio and J. Grasselli and G. Gueglio and P. Rad{\'i}o and Mariano Brzesinski and L. Pasik and Carla Pulero and A. {\'A}lvarez and H. Malagrino and P. G. Marchi{\~n}ena and A. Jurado and E. Joff{\'e} and M. Pallotta and L. Puricelli},
  journal={Cancer Research},
  year={2013},
  volume={73},
  pages={12-12}
}
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Clinicians face important pitfalls in the treatment of Renal cell carcinoma (RCC), such as absence of symptoms in early stages of the disease, its high metastatic potential and its resistance to conventional therapy. These facts emphasize the requirement of early diagnosis to optimize the chance of cure. ccRCC, the most common histological type of RCC, is considered a cell metabolic disease which develops from the… Expand
1 Citations